Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
第一作者:
Xianbin,Cai
第一单位:
Department of Gastroenterology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
作者:
主题词
氨基咪唑甲酰胺(Aminoimidazole Carboxamide);动物(Animals);癌, 肝细胞(Carcinoma, Hepatocellular);细胞存活(Cell Survival);细胞周期蛋白D1(Cyclin D1);周期素依赖激酶抑制剂p21(Cyclin-Dependent Kinase Inhibitor p21);周期素依赖激酶抑制剂p27(Cyclin-Dependent Kinase Inhibitor p27);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);Hep G2细胞(Hep G2 Cells);人类(Humans);肝肿瘤(Liver Neoplasms);二甲双胍(Metformin);小鼠(Mice);核糖核苷酸类(Ribonucleotides);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.3892/or.2013.2718
PMID
24008375
发布时间
2022-03-31
- 浏览43

Oncology reports
2449-57页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文